Jerad G. Seurer, General Counsel and Corporate Secretary of InMed Pharmaceuticals Inc. (now operating as Mentari Therapeutics, Inc.), filed an initial statement of beneficial ownership on November 12, 2026, reporting a stock option position received in connection with a corporate merger effective November 6, …
Gregory J. Divis, President and Chief Executive Officer of InMed Pharmaceuticals Inc. (now Mentari Therapeutics, Inc.), filed an initial statement of beneficial ownership on November 12, 2026, reporting a stock option position received in connection with a corporate merger effective November 6, 2026.
Laura Lee Sandler filed a Form 3 initial statement of beneficial ownership with the SEC on November 12, 2026, reporting her status as a newly appointed director of InMed Pharmaceuticals Inc. as of November 6, 2026.
Brett R. Hagen, Senior Vice President, Finance and Chief Accounting Officer of InMed Pharmaceuticals Inc. (now Mentari Therapeutics, Inc.), filed an initial statement of beneficial ownership on November 12, 2026, with a triggering event date of November 6, 2026.
Director Todd Shegog filed an initial statement of beneficial ownership with the SEC on November 12, 2026, reporting no securities beneficially owned in InMed Pharmaceuticals Inc. as of the event date of November 6, 2026.
Jeffrey Sonnenfeld filed an initial statement of beneficial ownership with the SEC on November 12, 2026, disclosing his status as a newly appointed director of Hyperliquid Strategies Inc as of November 4, 2026.
Edward Petit de Mange, VP of Recycling at Oklo Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 12, 2026, with a triggering event date of November 4, 2026.
Director Edward Dirk Hallen filed an initial statement of beneficial ownership with the SEC on November 12, 2026, reporting no securities beneficially owned in KLX Energy Services Holdings, Inc. as of the event date of October 29, 2026.
Darren W. Woodell, VP, Controller and Principal Accounting Officer at CarMax Inc, filed an initial statement of beneficial ownership with the SEC on November 12, 2026, with an event date of November 11, 2026.
Wang Yingrui, VP of Isotopes at Oklo Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 12, 2026, reporting a derivative security position as of a triggering event dated November 4, 2026.